NCT04566432View on ClinicalTrials.gov

Therapeutic ResistAnce and Clonal Evolution Assessed With Liquid Biopsy in ICIs Treated NSCLC Patients

RecruitingOBSERVATIONAL
Enrollment

250

Participants

Timeline

Start Date

July 1, 2020

Primary Completion Date

December 31, 2024

Study Completion Date

June 30, 2025

Conditions
Lung NeoplasmsLung Cancer, Nonsmall CellAdenocarcinoma of LungSquamous Cell Lung Cancer
Interventions
OTHER

Observation

observe the association of ctDNA with efficacy of treatment

Trial Locations (1)

Unknown

RECRUITING

Shanghai Chest Hospital, Shanghai

All Listed Sponsors
collaborator

Shanghai Chest Hospital

OTHER

lead

Geneplus-Beijing Co. Ltd.

INDUSTRY